| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040788608 |
| P356 | DOI | 10.1023/A:1009884820941 |
| P698 | PubMed publication ID | 16228142 |
| P2093 | author name string | Kannel WB | |
| P2860 | cites work | 1994 summary: National Hospital Discharge Survey | Q77092020 |
| Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995 | Q95807522 | ||
| Epidemiology of congestive heart failure: Canadian data from 1970 to 1989. | Q31006029 | ||
| Changing epidemiological features of cardiac failure | Q33614233 | ||
| Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). | Q34682919 | ||
| The epidemiology of heart failure: the Framingham Study | Q38512101 | ||
| Survival after the onset of congestive heart failure in Framingham Heart Study subjects | Q38512499 | ||
| Idiopathic cardiomyopathy in the United States, 1970-1982. | Q39729035 | ||
| Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions | Q43472007 | ||
| The clinical course of idiopathic dilated cardiomyopathy. A population-based study | Q43672288 | ||
| The progression from hypertension to congestive heart failure | Q43812016 | ||
| Trends in hospitalization for heart failure in Scotland 1980-1990. | Q44454010 | ||
| Epidemiology and risk profile of cardiac failure | Q50563246 | ||
| Epidemiology of heart failure | Q70112466 | ||
| Influence of heart rate on mortality among persons with hypertension: the Framingham Study | Q70642016 | ||
| Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy | Q71125977 | ||
| Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators | Q72232746 | ||
| Epidemiology of heart failure in the United States | Q72540999 | ||
| Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group | Q73108373 | ||
| Clinical epidemiology of coronary heart disease in the UK | Q73806497 | ||
| P433 | issue | 2 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 167-173 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Heart Failure Reviews | Q2167497 |
| P1476 | title | Incidence and epidemiology of heart failure | |
| P478 | volume | 5 |
| Q28577156 | 17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats |
| Q22306358 | 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q92150681 | A diabetes-associated genetic variant is associated with diastolic dysfunction and cardiovascular disease |
| Q42713685 | A juvenile murine heart failure model of pressure overload |
| Q37202333 | A nutritional program improved lipid profiles and weight in 28 chiropractic patients: a retrospective case series |
| Q35159504 | ATP-Sensitive Potassium Channel Currents in Eccentrically Hypertrophied Cardiac Myocytes of Volume-Overloaded Rats |
| Q37087291 | Absolute and attributable risks of heart failure incidence in relation to optimal risk factors |
| Q36712276 | Active components from Radix Scrophulariae inhibits the ventricular remodeling induced by hypertension in rats |
| Q45147864 | Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients. |
| Q37486273 | Aging of the United States population: impact on heart failure |
| Q34058253 | Aging, telomeres and heart failure |
| Q34179039 | Alcoholic cardiomyopathy |
| Q33876065 | An interactive-technology health behavior promotion program for heart failure patients: a pilot study of experiences and needs of patients and nurses in the hospital setting |
| Q92356922 | Analysis of National Health and Insurance Registers for All-Cause Mortality in Patients with Heart Failure with and without Diabetes Mellitus in Poland in 2012 |
| Q94551088 | Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats |
| Q44289310 | Association between left ventricular dysfunction, anemia, and chronic renal failure. Analysis of the Heart Failure Prevalence and Predictors in Turkey (HAPPY) cohort. |
| Q33691283 | Association of a common KCNE1 variant with heart failure |
| Q48054555 | Beneficial effects of exercise training in heart failure are lost in male diabetic rats. |
| Q34565614 | Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial |
| Q94337976 | Beta‐blockers for heart failure |
| Q38542448 | Cardiac Physiology of Aging: Extracellular Considerations. |
| Q37641566 | Cardiac effects of panhypopituitarism in a 71-year-old woman |
| Q38063294 | Cardiac resynchronization therapy for prevention of heart failure events in elderly patients with left ventricular dysfunction |
| Q58860070 | Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age |
| Q35566065 | Cardiac resynchronization: a brief synopsis part I: patient selection and results from clinical trials |
| Q51659834 | Cardiosphere conditioned media influence the plasticity of human mediastinal adipose tissue-derived mesenchymal stem cells. |
| Q37624268 | Cardiovascular disease in survivors of hematopoietic cell transplantation. |
| Q37643517 | Cheyne-stokes respiration in patients with heart failure |
| Q43244733 | Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats |
| Q48095390 | Clinical features of extremely elderly patients with heart failure. |
| Q34449256 | Community-based care for the specialized management of heart failure: an evidence-based analysis |
| Q46236269 | Comparisons of prognostic factors between young and elderly patients with chronic heart failure |
| Q36800887 | Complex cardiac pacing in the setting of a district general hospital: procedural success and complications |
| Q28575610 | Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload |
| Q37076287 | Contemporary management of pediatric heart failure |
| Q45430359 | Cost effectiveness of cardiac resynchronization therapy in the Nordic region: an analysis based on the CARE-HF trial. |
| Q43411786 | Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden |
| Q24685074 | Cystatin C and risk of heart failure in the Physicians' Health Study (PHS) |
| Q37735014 | Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy |
| Q39345174 | Demographic change and its impact on the health-care budget for heart failure inpatients in Germany during 1995-2025. |
| Q24654920 | Deregulation of RGS2 in cardiovascular diseases |
| Q27008211 | Determinants of adherence to heart failure medication: a systematic literature review |
| Q37963724 | Determinants of heart failure self-care: a systematic literature review |
| Q35922656 | Development of Motivate4Change Using the Intervention Mapping Protocol: An Interactive Technology Physical Activity and Medication Adherence Promotion Program for Hospitalized Heart Failure Patients. |
| Q37752042 | Diabetic cardiomyopathy--to take a long story serious |
| Q36501691 | Dilated cardiomyopathy: a tale of cytoskeletal proteins and beyond |
| Q47118252 | Disease management programs in chronic heart failure : Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology |
| Q24649661 | Does junk food lead to heart failure? Importance of dietary macronutrient composition in hypertension |
| Q47980746 | Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study |
| Q53132786 | Echocardiographic particle image velocimetry for the evaluation of diastolic function in hypertrophic nonobstructive cardiomyopathy. |
| Q44573481 | Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece |
| Q92296638 | Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies |
| Q45736855 | Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats |
| Q34429136 | Effects of combined aging and heart failure on visceral sympathetic nerve and cardiovascular responses to progressive hyperthermia in F344 rats |
| Q42759269 | Effects of lying position on P-wave dispersion in patients with heart failure |
| Q42837522 | Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result. |
| Q36380164 | Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study. |
| Q37929786 | Emerging drugs which target the renin-angiotensin-aldosterone system |
| Q57455660 | Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardium |
| Q42782593 | Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction. |
| Q34759702 | Epidemiological and evolutionary characteristics of heart failure in patients with left bundle branch block - A Moroccan center-based study |
| Q24630778 | Epidemiology and risk profile of heart failure |
| Q43462273 | Epidemiology of heart failure in a tertiary pediatric center. |
| Q37374537 | Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study |
| Q35277975 | Evaluation of training nurses to perform semi-automated three-dimensional left ventricular ejection fraction using a customised workstation-based training protocol |
| Q35862806 | Examining systemic steroid Use in older inflammatory bowel disease patients using hurdle models: a cohort study |
| Q58791854 | Excess risk of hospitalisation for heart failure among people with type 2 diabetes |
| Q36735375 | Experimental Studies on the Differentiation of Fibroblasts into Myoblasts induced by MyoD Genes in vitro |
| Q37538031 | Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association |
| Q37044313 | Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease |
| Q43601756 | Gender differences in the prevalence of metabolic syndrome in 50-year-old Swedish men and women with hypertension born in 1953. |
| Q49484266 | Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans. |
| Q33836293 | Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study |
| Q41992090 | HDAC4 controls histone methylation in response to elevated cardiac load |
| Q35870802 | Heart failure in nursing home residents; a cross-sectional study to determine the prevalence and clinical characteristics |
| Q38148978 | Heart failure in very old adults |
| Q43805197 | Heart failure. Optimal postdischarge management of chronic HF. |
| Q50099314 | High validity of cardiomyopathy diagnoses in western Sweden (1989-2009). |
| Q35012934 | High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets. |
| Q37248663 | Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination |
| Q89207832 | Histones and heart failure in diabetes |
| Q45807920 | Home-based telemanagement in chronic heart failure: an 8-year single-site experience |
| Q46760839 | Homocysteine research: alive and kicking! |
| Q37027541 | Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review |
| Q29416992 | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality |
| Q36648826 | Imidapril in heart failure |
| Q37142460 | Impact of adherence to statins on chronic heart failure in primary prevention |
| Q54029811 | Impact of better adherence to statin agents in the primary prevention of coronary artery disease. |
| Q46589863 | Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats |
| Q40525889 | Impact of guideline adherence on mortality in treatment of left heart failure |
| Q41554282 | Impact of the sustained control of cardiovascular risk factors on first episode heart failure: The relevant role of primary care. |
| Q34583369 | Impaired glucose tolerance, but not impaired fasting glucose, underlies left ventricular diastolic dysfunction |
| Q47831546 | In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. |
| Q45178052 | Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. |
| Q35604039 | Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation |
| Q37651588 | Incidence of seizures in the acute phase of stroke: a population-based study |
| Q33733431 | Incidence of ventricular arrhythmias after stem cell therapy in patients with Chagas cardiomyopathy |
| Q37170872 | Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure |
| Q36093418 | Introduction. Bioengineering the heart |
| Q28250382 | Lapatinib in the treatment of breast cancer |
| Q37777889 | Length of delay in seeking medical care by patients with heart failure symptoms and the role of symptom-related factors: a narrative review. |
| Q35975461 | Life Course Socioeconomic Position: Associations with Cardiac Structure and Function at Age 60-64 Years in the 1946 British Birth Cohort |
| Q91909836 | Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling |
| Q39859295 | Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy. |
| Q24625036 | Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation |
| Q42409105 | Lost in translation: modulation of the metabolic-functional relation in the diabetic human heart |
| Q44418625 | Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients |
| Q37175769 | Mechanisms of cardioprotection resulting from Brown Norway chromosome 16 substitution in the salt-sensitive Dahl rat. |
| Q38004307 | Mesenchymal stem cell therapy for heart disease. |
| Q39011735 | Metabolic enzymes dysregulation in heart failure: the prospective therapy |
| Q45944720 | Metabolic syndrome increases mortality in heart failure. |
| Q64912471 | Model-Based Quantification of Left Ventricular Diastolic Function in Critically Ill Patients with Atrial Fibrillation from Routine Data: A Feasibility Study. |
| Q35667311 | Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling |
| Q34420636 | Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials |
| Q38806467 | Myocardial dysfunction and cardiovascular disease in type 2 diabetes |
| Q37227932 | National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. |
| Q33902623 | Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure |
| Q37257464 | Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials |
| Q35815348 | Non-symptom-related factors contributing to delay in seeking medical care by patients with heart failure: a narrative review |
| Q58859955 | Nonlinear Indices of Heart Rate Variability in Chronic Heart Failure Patients: Redundancy and Comparative Clinical Value |
| Q90333242 | Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP) |
| Q39291134 | Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence? |
| Q33309505 | Peripheral Arterial Disease study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality |
| Q36862282 | Physiology and clinical significance of natriuretic hormones |
| Q37365774 | Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians |
| Q33932770 | Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy |
| Q49977772 | Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study |
| Q58416774 | Polymeric Scaffolds for Bioartificial Cardiovascular Prostheses |
| Q36682368 | Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy |
| Q42799896 | Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study |
| Q30375842 | Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction: A Population-Based Study in Northeast China. |
| Q33777255 | Prevalence and risk factors of heart failure in the USA: NHANES 2013 - 2014 epidemiological follow-up study. |
| Q30317850 | Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study |
| Q30915732 | Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart |
| Q23917174 | Pulmonary function and left ventricular mass in African Americans: The Atherosclerosis Risk in Communities (ARIC) study |
| Q83198171 | QRS duration is associated with atrial fibrillation in patients with left ventricular dysfunction |
| Q36201155 | Racial and ethnic differences in incident hospitalized heart failure in postmenopausal women: the Women's Health Initiative |
| Q33692727 | Racial differences in incident heart failure among young adults |
| Q38156683 | Recent advances in metabolic imaging |
| Q34571982 | Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults |
| Q37389532 | Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study |
| Q38705567 | Remote monitoring of heart failure: benefits for therapeutic decision making. |
| Q34777786 | Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications |
| Q36535063 | Residential exposure to traffic-related air pollution and survival after heart failure |
| Q42367637 | Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface |
| Q37769156 | Risk factors preceding type 2 diabetes and cardiomyopathy |
| Q35001969 | Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative. |
| Q37121699 | Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis. |
| Q38903885 | Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure |
| Q37654714 | Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage |
| Q36184665 | Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer |
| Q35587939 | Telomere dynamics unique to meiotic prophase: formation and significance of the bouquet |
| Q37410498 | Temporal Development of Autonomic Dysfunction in Heart Failure: Effects of Age in an Ovine Rapid-pacing Model |
| Q33977051 | The ABC transporter structure and mechanism: perspectives on recent research. |
| Q36447299 | The average lifespan of patients discharged from hospital with heart failure |
| Q46984817 | The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing |
| Q48101707 | The contribution of comorbidities to mortality in hospitalized patients with heart failure. |
| Q33723328 | The dietary quality of persons with heart failure in NHANES 1999-2006 |
| Q38611592 | The economic impact of patients with heart failure on the Lebanese healthcare system. |
| Q35811855 | The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure |
| Q55078568 | The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions. |
| Q42648084 | The involvement of lysosomes in myocardial aging and disease |
| Q92296471 | The relationship between pubertal timing and markers of vascular and cardiac structure and function in men and women aged 60-64 years |
| Q21093273 | The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome |
| Q27002139 | Top-down proteomics in health and disease: challenges and opportunities |
| Q43284147 | Trimetazidine: the future of cardiac function? |
| Q37895302 | Up-regulation of the cardiac lipid metabolism at the onset of heart failure. |
| Q37738006 | Uric acid as a factor in the metabolic syndrome. |
| Q85239671 | Use of Gated Cardiac Computed Tomography Angiography in the Assessment of Left Ventricular Assist Device Dysfunction |
| Q42961720 | Use of afterload hemodynamic stress as a practical method for assessing cardiac performance in rats with heart failure |
| Q33870759 | Use of remote monitoring to improve outcomes in patients with heart failure: a pilot trial |
| Q36526889 | Vitamin D insufficiency in congestive heart failure: why and what to do about it? |
| Q24669903 | White coat hypertension: relevance to clinical and emergency medical services personnel |
| Q52905666 | [Is the determination of biomarkers worth its price? Review of the literature taking brain natriuretic peptides (BNP) as an example]. |
| Q57068598 | miR‑127 aggravates myocardial failure by promoting the TGF‑β1/Smad3 signaling |
| Q29347283 | p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress |
Search more.